Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Results 1-10 of 10 for your search:
Start Over
Pomalidomide in Treating Patients with Kaposi Sarcoma with or without HIV
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0047, NCI-2013-01525, 120047, P11847, PO-KS-NCI-0050, NCT01495598
Pegylated Liposomal Doxorubicin Hydrochloride and Bevacizumab in Treating Patients with Advanced Kaposi Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-C-0130, NCI-2013-01450, 090130, NCT00902239, P09493, NCT00923936
Nivolumab and Ipilimumab in Treating Patients with Advanced HIV Associated Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: AMC-095, NCI-2015-00461, PAMC-095_R03PAPP01, NCT02408861
Pembrolizumab in Treating Patients with HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-12, NCI-2015-01906, NCT02595866
Pomalidomide and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Advanced or Refractory Kaposi Sarcoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-C-0047, NCI-2016-00067, P152279, NCT02659930
Iodine I 124-FIAU Positron Emission Tomography And Computed Tomography in Assessing Viral Expression in Patients with Epstein-Barr Virus and Kaposi Sarcoma Herpes Virus-Associated Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 to 75
Trial IDs: J09111, NCI-2009-01398, NA_00032681 / CIR00009387, NCT00982449
Collecting and Storing Blood, Bone Marrow, Tumor, or Normal Tissue Samples From Patients with HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, or Cancer
Status: Active
Phase: No phase specified
Type: Tissue collection/Repository
Age: 18 and over
Trial IDs: 01-C-0038, NCI-2013-02020, 010038, NCT00898651, NCT00006518
Natural History of Zidovudine and Valganciclovir or Rituximab and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients with Kaposi Sarcoma-Associated Herpes Virus
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Age: 18 and over
Trial IDs: 11-C-0220, NCI-2013-01499, 110220, P10760, NCT01419561
Natural History Studies in Samples from Patients with Rare Skin Diseases or Diseases with Skin Involvement
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Any age
Trial IDs: 96-C-0102, NCI-2013-02070, 960102, NCT00019149, NCT00001506
Laser Doppler Imaging, Multi-Spectral Imaging, Infrared Thermal Imaging, and Optical Coherence Tomography in Assessing Tumor Vascularity in Patients with Kaposi Sarcoma
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 01-C-0158, NCI-2013-02024, 010158, NIH-2514-1 (07-09), P.A.: 09-25-0099, NCT00026793
Start Over